The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 07, 2022

Filed:

Jun. 24, 2019
Applicants:

The Sydney Children's Hospitals Network (Randwick and Westmead) (Incorporating the Royal Alexandra Hospital for Children, Westmead, AU;

Children's Medical Research Institute, Westmead, AU;

Mount Sinai Hospital, Toronto, AU;

Inventors:

Ian Alexander, Middle Dural, AU;

Sharon Cunningham, North Parramatta, AU;

Andras Nagy, Toronto, CA;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 48/00 (2006.01); C12N 15/86 (2006.01); C12N 9/00 (2006.01); C12N 9/10 (2006.01); C12N 9/12 (2006.01); C12N 9/14 (2006.01);
U.S. Cl.
CPC ...
A61K 48/0066 (2013.01); A61K 48/005 (2013.01); A61K 48/0041 (2013.01); C12N 9/1018 (2013.01); C12N 9/1241 (2013.01); C12N 9/14 (2013.01); C12N 9/93 (2013.01); C12N 15/86 (2013.01); C12Y 201/03003 (2013.01); C12Y 207/07 (2013.01); C12Y 306/03044 (2013.01); C12Y 603/04005 (2013.01); C12N 2750/14143 (2013.01); C12N 2800/90 (2013.01); C12N 2840/007 (2013.01);
Abstract

Provided herein are methods for facilitating or inducing stable transgene integration and expression in a proliferating cell, comprising administering to the cell (i) a recombinant AAV (rAAV) vector comprising the transgene flanked by transposon-derived inverted terminal repeat sequences, which sequences are in turn flanked by AAV-derived inverted terminal repeat regions, and (ii) a source of a transposase that recognises said transposon-derived inverted terminal repeat sequences and directs the genomic integration of the transgene into the genome of the proliferating cell. Also provide are methods and transgene delivery systems for the treatment or prevention of diseases affecting, associated with or characterised by proliferating cells.


Find Patent Forward Citations

Loading…